tiprankstipranks
Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
US Market
CNTA
Centessa Pharmaceuticals
RESEARCH TOOLSreports

Centessa Pharmaceuticals (CNTA) Financial Statements

235 Followers

Centessa Pharmaceuticals Financial Overview

Centessa Pharmaceuticals's market cap is currently $5.89B. The company's EPS TTM is $-0.4; its P/E ratio is -17.18; Centessa Pharmaceuticals is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 15.00M$ 0.00$ 6.85M$ 0.00$ 0.00
Gross Profit$ 15.00M$ 0.00$ 6.85M$ 0.00$ 0.00
Operating Income$ -207.69M$ -201.06M$ -171.28M$ -212.26M$ -374.87M
EBITDA$ -207.69M$ -221.88M$ -165.43M$ -209.55M$ -139.30M
Net Income$ -197.53M$ -235.76M$ -151.09M$ -216.21M$ -381.90M
Balance Sheet
Cash & Short-Term Investments$ 294.58M$ 482.18M$ 256.55M$ 393.64M$ 595.08M
Total Assets$ 687.50M$ 576.80M$ 360.25M$ 444.31M$ 629.63M
Total Debt$ 7.57M$ 117.23M$ 84.59M$ 69.80M$ 75.70M
Net Debt$ -53.73M$ -266.00M$ -43.44M$ -323.84M$ -519.38M
Total Liabilities$ 160.63M$ 175.25M$ 124.00M$ 108.14M$ 138.08M
Stockholders' Equity$ 526.86M$ 401.55M$ 236.24M$ 336.17M$ 491.55M
Cash Flow
Free Cash Flow$ -194.19M$ -142.09M$ -160.51M$ -201.68M$ -136.33M
Operating Cash Flow$ -193.82M$ -142.06M$ -160.34M$ -200.55M$ -136.14M
Investing Cash Flow$ -418.53M$ 31.27M$ -127.00M$ -931.00K$ 63.25M
Financing Cash Flow$ 291.53M$ 364.75M$ 21.12M$ 457.00K$ 660.07M
Currency in USD

Centessa Pharmaceuticals Earnings and Revenue History

Income Statement >

Centessa Pharmaceuticals Debt to Assets

Balance Sheet >

Centessa Pharmaceuticals Cash Flow

Cash Flow >

Centessa Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >